Small volume collection chamber

Claim 3

The device of claim 1 including a container having the inlet, outlet, and area for receiving mononuclear cells.

Claim 4

The device of claim 1 including: an at least-semi-rigid plate including recessed areas defining an inlet, outlet, and an area for receiving mononuclear cells; a substantially rigid plate for mating with the at least semi-rigid plate; and a flexible container that is sandwiched between the substantially rigid wall and semi-rigid wall for receiving the mononuclear cells.

Claim 5

The device of claim 1 wherein the centrifuge blood cell separator exerts at least four different G forces on the device, at least a portion of an inlet fluid path experiencing a G force of R3, at least a portion of an outlet fluid path a G force of R2, at least a portion of the cavity a G force of R5, and at least a portion of a fluid path between the inlet and outlet a G force of R1, wherein: R5>R3>R2>R1.

Claim 6

The device of claim 1 wherein, on average, at least 80% of the platelets flow through the outlet.

Claim 7

A container for receiving and collecting mononuclear cells separated from red blood cell depleted plasma, for use in a blood separator comprising: a body defining a cavity for receiving and collecting mononuclear cells and including an inlet for receiving plasma and defining an inlet flow path and an outlet for receiving plasma and directing the plasma out of the cavity, the outlet defining an outlet flow path, the inlet and outlet being located at a top portion of the cavity; and the body defining a flow path directly from the inlet flow path to the outlet flow path at a top portion of the cavity, the distance between the inlet and outlet being such that at least 66% of the platelet cells contained in the plasma are caused by the inlet flow path to be directed to the outlet flow path and through the outlet and mononuclear cells sediment out and are collected in the cavity.

Claim 8

A container for receiving and collecting mononuclear cells separated from red blood cell depleted plasma, for use in a blood separator comprising: a body defining a cavity for receiving and collecting mononuclear cells and including an inlet for receiving plasma and defining an inlet flow path and an outlet for receiving plasma and directing the plasma out of the cavity, the outlet defining an outlet flow path, the inlet and outlet being located at a top portion of the cavity; and the body defining a flow path directly from the inlet flow path to the outlet flow path at a top portion of the cavity, the distance between the inlet and outlet being such that at least 66% of the platelet cells contained in the plasma are caused by the inlet flow path to be directed to the outlet flow path and through the outlet and mononuclear cells sediment out and are collected in the cavity.

Claim 9

The container of claim 6 wherein the inlet flow path includes a substantially straight portion that terminates into a dogleg portion.

Claim 10

The container of claim 6 wherein the inlet flow path has a sufficiently small cross-sectional shape to ensure a sufficiently great velocity of the plasma through the inlet flow path.

Claim 11

The container of claim 6 including a first plate for receiving portions of the container and a second plate for mating with the first plate and sandwiching the container therebetween.

Claim 12

The container of claim 6 wherein the centrifuge blood cell separator exerts at least four different G forces on the container, at least a portion of the inlet fluid path experiencing a G force of R3, at least a portion of the outlet fluid path experiencing a G force of R2, at least a portion of the cavity experiencing a G force of R5, and a fluid path between the inlet and outlet experiencing a G force of R1, wherein: R5>R3×R2>R1.

Claim 13

The container of claim 7 wherein the centrifuge blood separator exerts at least five different G forces on the container, at least a portion of the outlet fluid experience a G force of R2, at least a portion of the cavity experiencing a G force of R5, a fluid path between the inlet and outlet experiencing a G force of R1, the substantially straight portion experiences a G force of R3 and the dogleg portion experiences a G force of R4, wherein: R5>R4>R3>R2×R1.

Claim 14

The container of claim 6 wherein, on average, at least 80% of the platelets that flow into the container flow out of the container.

Claim 15

A chamber for separating and collecting mononuclear cells from a red blood cell depleted plasma comprising: a flexible container including a cavity having a top portion and a bottom portion for receiving mononuclear cells and including an inlet and an outlet; a first plate including recessed means for defining within the container an inlet path, the cavity, and an outlet path, the inlet path and outlet path being located at a top portion of the cavity; a second plate that mates with the first plate for sandwiching the container therebetween; and the inlet path and outlet path define means for creating a flow path across the top portion of the cavity directly from the inlet path and outlet path and for causing mononuclear cells to sediment out and collect in the cavity and cause at least 66% of the platelets in the plasma that enters the container through the inlet to exit the container through the outlet.

Claim 16

A chamber for separating and collecting mononuclear cells from a red blood cell depleted plasma comprising: a flexible container including a cavity having a top portion and a bottom portion for receiving mononuclear cells and including an inlet and an outlet; a first plate including recessed means for defining within the container an inlet path, the cavity, and an outlet path, the inlet path and outlet path being located at a top portion of the cavity; a second plate that mates with the first plate for sandwiching the container therebetween; and the inlet path and outlet path define means for creating a flow path across the top portion of the cavity directly from the inlet path and outlet path and for causing mononuclear cells to sediment out and collect in the cavity and cause at least 66% of the platelets in the plasma that enters the container through the inlet to exit the container through the outlet.

Claim 17

The chamber of claim 13 wherein the inlet path includes a first substantially straight portion that terminates in a dogleg portion that terminates in a second substantially straight portion substantially perpendicular to the first substantially straight portion.

Claim 18

The chamber of claim 13 wherein the outlet path includes a substantially straight portion.

Claim 19

The container of claim 13 wherein the inlet flow path has a sufficiently small cross-sectional shape to ensure a sufficiently great velocity of the plasma through the inlet flow path.

Claim 20

The device of claim 13 wherein the centrifuge blood cell separator exerts at least four different G forces on the device, at least a portion of the inlet path experiencing a G force of R3, the outlet path a G force of R2, the cavity a G force of R5, and a path between the inlet and outlet a G force of R1, wherein: R5>R3>R2>R1.

Claim 21

The container of claim 17 wherein the inlet path includes a substantially straight portion and dogleg portion and the substantially straight portion experiences a G force of R3 and the dogleg portion experiences a G force of R4, wherein: R5>R4>R3>R2>R1.

Claim 22

The chamber of claim 13 wherein the first plate is constructed from a semi-rigid material.

Claim 23

The chamber of claim 13 wherein the second plate is constructed from a rigid material.

Claim 24

The chamber of claim 13 wherein at least approximately 80% of the platelets in the plasma that enter the container exit the container.

Claim 27

The method of claim 22 wherein the G forces exerted by the centrifuge on the plasma are as follows: R3 on at least a first portion of the first flow path; R1 at the second flow path; and R2 at the third flow path; wherein: R3>R2>R1.

Claim 28

The method of claim 22 wherein the G forces exerted by the centrifuge on the plasma are R5 at the cavity and R5>R3>R2>R1.

Claim 29

The method of claim 23 wherein the G forces at a second portion of the first flow path are R4 and R5>R4>R3>R2>R1.

Claim 30

The method of claim 22 wherein plasma is removed intervivos from a patient/donor.

Claim 31

A method of claim 26 wherein after flowing through the outlet flow path mononuclear cell depleted plasma is reinfused into the patient/donor.

Claim 32

The method of claim 22 wherein at least approximately 80% of the platelets in the plasma are prevented from sedimenting out.

Claim 33

A chamber for separating and collecting mononuclear cells and including an outlet located at a top portion of the container; a first plate including recessed means for defining within the container an inlet path, the cavity, and an outlet path; the inlet path includes a first substantially straight portion that terminates in a dogleg portion that terminates in a second substantially straight portion that is substantially perpendicular to the first substantially straight portion; a second plate that mates with the first plate for sandwiching the container therebetween; and the inlet path and outlet path define therebetween a direct flow path across a top of the cavity for causing mononuclear cells to sediment out and collect in the cavity.

Claim 34

A chamber for separating and collecting mononuclear cells and including an outlet located at a top portion of the container; a first plate including recessed means for defining within the container an inlet path, the cavity, and an outlet path; the inlet path includes a first substantially straight portion that terminates in a dogleg portion that terminates in a second substantially straight portion that is substantially perpendicular to the first substantially straight portion; a second plate that mates with the first plate for sandwiching the container therebetween; and the inlet path and outlet path define therebetween a direct flow path across a top of the cavity for causing mononuclear cells to sediment out and collect in the cavity.

Claim 35

The chamber of claim 29 wherein the outlet path includes a substantially straight portion.

Claim 36

The chamber of claim 29 wherein at least 66% of the platelets contained within the plasma entering the container exit the container.